Clarithromycin Price Trend and Forecast 2026-2027

Clarithromycin API pricing kept sliding through the first half of 2026, and Even Germany, which came in priciest of the four this quarter, could not escape the slide despite its premium high-purity positioning. Prices there eased from USD 445/KG in Q1 to USD 418/KG in Q2, down 6.1%. The global average dropped from USD 328/KG to USD 305/KG, about 7.0%. This is really a China Plus One story. Buyers have been actively diversifying away from single-source Chinese supply since 2025, and India's expanding capacity, backed by production-linked incentives, is absorbing a growing share of that demand at increasingly competitive prices. A global average of USD 285-320/KG looks likely through H2 2026, with continued Indian capacity additions the biggest downward pressure on the horizon.

Clarithromycin is a semi-synthetic macrolide antibiotic used to treat respiratory tract infections, skin infections, and, in combination therapy, Helicobacter pylori-associated ulcers. It's manufactured through fermentation of erythromycin followed by a series of chemical modifications, and traded globally as bulk active pharmaceutical ingredient for downstream tablet and oral liquid formulation. China leads global exports by a wide margin, while India is the largest single importer and is rapidly scaling its own domestic API capacity. Regulatory scrutiny around nitrosamine impurities has opened up a genuine price premium for producers who can demonstrate ultra-clean batches, even as the broader commodity-grade market keeps softening.

What moves this market comes down to Chinese fermentation capacity and export pricing, India's own capacity build-out under its PLI scheme, nitrosamine-related purity premiums, and downstream demand from generic tablet and combination-therapy manufacturers.

Clarithromycin Price Forecast for 2026

Don't expect this slide to reverse anytime soon. India's capacity additions, backed by government incentives aimed at reducing dependence on Chinese intermediates, are still ramping up, and every new production line that comes online adds competitive pressure on price. Chinese producers, who still control the bulk of global fermentation capacity, have been defending market share rather than margin, which keeps commodity-grade pricing under consistent pressure. The one bright spot is at the top end of the market: producers who can reliably hit the tightened nitrosamine impurity thresholds that regulators in North America and Europe have imposed are commanding a real premium, and that gap between commodity and high-purity grades looks likely to widen rather than close.

A supply disruption at a major Chinese fermentation facility, or a delay in Indian capacity ramp-up, would be the clearest path to prices firming back above the forecast range. The more likely path runs the other way, though: continued Indian capacity additions and persistent Chinese export competition would keep easing prices below the forecast, particularly in the commodity-grade segment.

For the Quarter Ending June 2026

Clarithromycin Prices Q2 2026:

• Germany: USD 418/KG
• United States: USD 362/KG
• India: USD 268/KG
• China: USD 228/KG

Clarithromycin Prices in Germany

Germany averaged USD 418/KG in Q2 2026, the priciest region in this report even as it fell 6.1% from Q1's USD 445/KG, with broader commodity-grade softening finally reaching the high-purity segment.

Why did the price of Clarithromycin change in Q2 2026 in Germany?

Even nitrosamine-clean, high-purity batches felt some pull from the broader commodity-grade decline this quarter, though the premium over standard API held up better than the headline number suggests. Buyers in strict regulatory environments kept paying for guaranteed purity documentation, which is really what limited the decline here compared to China and India.

Clarithromycin Prices in the United States

The US came in at USD 362/KG in Q2 2026, down 5.7% from USD 384/KG in Q1, tracking the broader softening while still holding a real premium over commodity-grade product.

Why did the price of Clarithromycin change in Q2 2026 in the United States?

US buyers continued favoring suppliers who could demonstrate clean nitrosamine profiles, and that demand held the decline here more modest than in the commodity-grade Asian markets. Generic formulators kept placing steady orders even as the underlying API price eased.

Clarithromycin Prices in India

India averaged USD 268/KG in Q2 2026, down 7.9% from USD 291/KG in Q1, as expanding domestic capacity kept adding competitive pressure.

Why did the price of Clarithromycin change in Q2 2026 in India?

New production lines backed by India's pharmaceutical incentive scheme kept coming online through the quarter, and that additional capacity is what really pushed the price down here faster than in the premium Western markets. Domestic formulators benefited directly from the lower feedstock cost.

Clarithromycin Prices in China

China averaged USD 228/KG in Q2 2026, down 8.1% from USD 248/KG in Q1, a steeper drop than anywhere else in this report.

Why did the price of Clarithromycin change in Q2 2026 in China?

Chinese exporters kept defending market share against the rising Indian competition rather than holding the line on price, and that strategy is what drove the sharpest decline of any market covered here. Large-scale fermentation capacity gives Chinese producers room to compete on price even as margins compress.

For the Quarter Ending March 2026

Clarithromycin Prices Q1 2026:

• Germany: USD 445/KG
• United States: USD 384/KG
• India: USD 291/KG
• China: USD 248/KG

Clarithromycin Prices in Germany

Germany opened Q1 2026 at USD 445/KG.

High-purity, nitrosamine-clean API continued commanding a strong premium through the quarter, with regulated buyers in Europe unwilling to compromise on documentation standards even as commodity-grade prices softened elsewhere. Demand for combination H. pylori therapy kits added further support.

Why did the price of Clarithromycin change in Q1 2026 in Germany?

This is a segment where documentation costs more than raw manufacturing does, so buyers rarely walk away from a qualified supplier over a small price gap. That inertia is a big part of why Germany's decline lagged the commodity-grade markets covered later in this report.

Clarithromycin Prices in the United States

US pricing for Q1 2026 settled at USD 384/KG.

US regulatory scrutiny around impurity profiles kept purity-verified suppliers in high demand, supporting a real premium over the broader commodity market. Generic tablet manufacturers maintained steady procurement through the quarter.

Why did the price of Clarithromycin change in Q1 2026 in the United States?

Generic manufacturers here operate under similar documentation pressure to their European counterparts, which is part of why the US premium held up in a quarter when commodity-grade Asian supply was already getting cheaper.

Clarithromycin Prices in India

India came in at USD 291/KG for Q1 2026.

Domestic capacity continued expanding through the quarter as new PLI-backed production lines ramped toward full output. Export demand from Southeast Asian and African buyers added incremental support even as domestic pricing trended lower.

Why did the price of Clarithromycin change in Q1 2026 in India?

Each new PLI-backed line effectively adds fresh competitive tonnage to a market that was already softening, and that capacity math is really the story behind why India's decline outpaced the premium Western markets this quarter.

Clarithromycin Prices in China

USD 248/KG was where China settled for Q1 2026.

Chinese export volumes stayed strong through the quarter even as pricing softened, a deliberate strategy to defend market share against rising Indian competition. Large fermentation capacity gave producers room to accept thinner margins.

Why did the price of Clarithromycin change in Q1 2026 in China?

Chinese producers can afford to run this playbook because their cost base sits well below the rest of the market, giving them room to keep shipping volume even as unit economics get thinner.

Quarterly Clarithromycin Price Trends

Six quarters of clarithromycin pricing tell a consistent story of erosion, not volatility. The global average moved from USD 385/KG in Q2 2025 to USD 368/KG in Q3, USD 348/KG in Q4, USD 328/KG in Q1 2026, then USD 305/KG in Q2 2026, a net decline of about 20.8% across the window. India's capacity build-out under its pharmaceutical incentive scheme, combined with China's willingness to defend export volume over margin, is what's kept this trend so consistently downward, quarter after quarter, with no real reversal in sight.

What was Clarithromycin Price in 2025?

2025 was already a year of steady decline for clarithromycin, well before the sharper drop that carried into 2026. The global average opened near USD 412/KG in Q1 and closed at USD 348/KG by Q4, a full-year decline of 15.5%. India's growing capacity, still ramping through most of the year, combined with persistent Chinese export competition to keep the market moving in one direction, with no meaningful demand-side offset strong enough to reverse the trend.

Clarithromycin Prices in Germany in 2025

Germany held up best against the broader decline among the regions covered here, slipping from USD 512/KG in Q1 2025 to USD 468/KG by Q4, a drop of 8.6%. High-purity, nitrosamine-clean product held its premium far better than commodity grade did, since regulated European buyers simply were not willing to compromise on documentation standards regardless of what the broader market was doing.

Clarithromycin Prices in the United States in 2025

Regulatory scrutiny on impurity profiles is what kept the US decline relatively contained, from USD 438/KG in Q1 2025 down to USD 402/KG by Q4, about 8.2% for the year. Purity-verified suppliers commanded a real premium throughout, insulating this market from the sharper drops seen in the commodity-grade Asian markets.

Clarithromycin Prices in India in 2025

New PLI-backed capacity kept coming online in India throughout the year, and each additional production line added competitive pressure that domestic formulators were happy to capture as lower input costs. The price fell from USD 336/KG in Q1 2025 to USD 305/KG by Q4, a decline of 9.2%.

Clarithromycin Prices in China in 2025

No region fell further than China, which went from USD 292/KG in Q1 2025 down to USD 258/KG by Q4, about 11.6% for the year. Export volumes stayed strong the whole time even as unit pricing fell, a strategy that prioritized market share over margin as Indian competition intensified.

How We Can Help

Expert Market Research: Your Source for Real-Time Clarithromycin Price Intelligence

Expert Market Research follows clarithromycin API pricing closely, across every major producing and consuming region. We weigh Chinese fermentation capacity, India's PLI-backed expansion, nitrosamine purity premiums, and downstream generic demand together, since a price number without the reasoning behind it doesn't help you plan procurement. Our forecasts pull from capacity utilization figures, trade flow analysis, and regulatory tracking across the regions we cover. Get in touch with our team for clarithromycin pricing data, custom market analysis, or procurement strategy support.